UCSF
San Francisco, California, 94110, United States
Location contact
Amanda Fragoso
CONTACT
David Bayne, MD
CONTACT
David Bayne, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07322172
Patients who visit the emergency department for kidney stones are sometimes referred to urology for follow-up care but never complete that visit. Missing follow-up appointments can lead to worse outcomes, including recurrent pain, infection, or surgery. Research shows that patients who are socially or economically at risk (such as those with public insurance, lower income, or limited English proficiency) are more likely to experience these care gaps.
This study will pilot a patient navigation program designed to help patients with urinary stone disease (USD) attend their scheduled urology appointments after being seen in the Emergency Department. Using an electronic health record (EHR) based prediction model developed in earlier research, patients at higher risk for being lost to follow-up will be identified and invited to participate. Each participant will be paired with a trained patient navigator who will assess barriers to care, provide support, and maintain contact for about 12 weeks.
The goal of this study is to evaluate the outcomes and feasibility of this navigation intervention. Findings will help determine whether a larger study should test if this approach improves access to care and health outcomes for patients with kidney stones.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
San Francisco, California, 94110, United States
Amanda Fragoso
CONTACT
David Bayne, MD
CONTACT
David Bayne, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consists of a patient navigation program delivered by a patient navigator over approximately 12 weeks. Participants identified as high risk for loss to follow-up after an emergency department visit for kidney stone disease will receive individualized navigation support focused on identifying and addressing barriers to urology follow-up. Navigation activities may include care coordination support, appointment scheduling guidance, health education, linkage to existing institutional or community resources (transportation assistance or insurance enrollment support), and motivational support. The patient navigator will maintain regular contact with participants through in-person, phone, or virtual encounters, and navigation activities will be documented in a secure research database. The intervention is designed to support access to recommended care and does not alter clinical treatment decisions.
Time frame: From enrollment to the end of intervention at 12 weeks
Time frame: From enrollment to the end of treatment at 12 weeks
Acceptability will be assessed using the Patient Navigation Process and Outcomes Measure (PNPOM), a validated questionnaire administered to patient participants at the completion of the intervention. The PNPOM evaluates participants' perceptions of the navigation experience, including satisfaction, perceived usefulness, and support received. Responses are scored on a Likert-type scale, with higher scores indicating greater acceptability of the navigation intervention. The total score will be summarized descriptively to assess overall intervention acceptability.
Contact information is provided by the study sponsor or research team.
University of California, San Francisco
Other
Pilot Study of Patient Navigation Intervention to Improve Follow-up Care for Patients With Urinary Stone Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712861
Calculi, Female Urogenital Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07705646
Calculi, Female Urogenital Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07389226
Calculi, Female Urogenital Diseases
Chicago, Illinois, United States
View Trial DetailsNCT07512297
Agnosia, Calculi
Gaziantep, Turkey, Turkey (Türkiye)
View Trial Details